Amexdrug Corporation
AXRX
$0.002
$0.000.00%
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Net Income | 1,355.26% | 269.29% | -18.47% | -111.57% | -95.87% |
| Total Depreciation and Amortization | 437.63% | 335.00% | 201.54% | 102.00% | 82.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.67% | -2.08% | -24.00% | -139.33% | -135.62% |
| Change in Net Operating Assets | -7,622.22% | -737.78% | -6.61% | -31.82% | 101.14% |
| Cash from Operations | -806.60% | -1,221.52% | -17.36% | -525.56% | 202.86% |
| Capital Expenditure | -1,382.32% | -987.26% | -981.60% | 50.18% | -141.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 383.33% | 1,400.00% | -180.00% | -135.29% | -110.53% |
| Cash from Investing | -1,348.90% | -981.65% | -1,054.39% | 44.74% | -340.28% |
| Total Debt Issued | 152.04% | 43.11% | 43.11% | 765.13% | 454.92% |
| Total Debt Repaid | 42.96% | 183.51% | -- | 200.00% | -1,199.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 30.43% | 57.14% | 64.00% | -35.29% | -27.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -194.83% | -324.49% | -382.05% | 233.33% | 231.82% |
| Cash from Financing | 2,322.10% | 1,304.69% | 38.80% | 2,839.76% | -234.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.85% | 98.70% | -219.08% | 258.25% | -398.75% |
